science π¬ Indian scientists create smart cancer drug candidate
Indian scientists have developed a new cancer drug candidate, RK-251, aiming for targeted tumor cell treatment. The research was led by Dr. Asis Bala of the Institute of Advanced Study in Science and Technology and Dr. K.P. Bhabak of IIT Guwahati. In preclinical tests, RK-251 showed strong activity against aggressive triple-negative breast cancer cells. The drug activates inside tumors by using high levels of reactive oxygen species, releasing NBDHEX. Further lab research and clinical trials are needed before this promising candidate reaches patients. π¬